GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (FRA:OJU1) » Definitions » Cyclically Adjusted PB Ratio

Oramed Pharmaceuticals (FRA:OJU1) Cyclically Adjusted PB Ratio : 0.81 (As of Jun. 06, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Oramed Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Oramed Pharmaceuticals's current share price is €1.926. Oramed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.38. Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 0.81.

The historical rank and industry rank for Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:OJU1' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.7   Med: 3.77   Max: 16.95
Current: 0.8

During the past years, Oramed Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 16.95. The lowest was 0.70. And the median was 3.77.

FRA:OJU1's Cyclically Adjusted PB Ratio is ranked better than
67.78% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs FRA:OJU1: 0.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oramed Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was €3.784. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.38 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Oramed Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Oramed Pharmaceuticals Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 2.39 11.67 5.32 0.88

Oramed Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 1.45 1.02 0.88 1.09

Competitive Comparison of Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Oramed Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.926/2.38
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oramed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Oramed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.784/131.7762*131.7762
=3.784

Current CPI (Mar. 2024) = 131.7762.

Oramed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201405 1.607 100.373 2.110
201408 1.546 100.352 2.030
201411 1.758 99.635 2.325
201502 1.819 99.032 2.420
201505 1.761 100.333 2.313
201508 1.928 100.548 2.527
201511 1.811 100.135 2.383
201602 2.250 100.040 2.964
201605 2.086 101.355 2.712
201608 1.772 101.617 2.298
201611 1.676 101.829 2.169
201702 1.506 102.779 1.931
201705 1.346 103.256 1.718
201708 1.192 103.587 1.516
201711 1.354 104.072 1.714
201802 1.152 105.052 1.445
201805 0.974 106.148 1.209
201808 1.551 106.383 1.921
201811 1.461 106.338 1.811
201902 1.285 106.649 1.588
201905 1.109 108.048 1.353
201908 1.003 108.245 1.221
201911 0.892 108.519 1.083
202002 0.639 109.139 0.772
202005 1.344 108.175 1.637
202008 1.173 109.662 1.410
202011 1.002 109.793 1.203
202102 1.445 110.968 1.716
202105 1.837 113.576 2.131
202108 2.788 115.421 3.183
202111 3.914 117.269 4.398
202203 3.823 121.301 4.153
202206 3.770 125.017 3.974
202209 3.972 125.227 4.180
202212 3.622 125.222 3.812
202303 3.528 127.348 3.651
202306 3.478 128.729 3.560
202309 3.469 129.860 3.520
202312 3.724 129.419 3.792
202403 3.784 131.776 3.784

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oramed Pharmaceuticals  (FRA:OJU1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Oramed Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oramed Pharmaceuticals (FRA:OJU1) Business Description

Traded in Other Exchanges
Address
1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Oramed Pharmaceuticals (FRA:OJU1) Headlines

No Headlines